Coverage prerequisites for initial PAP therapy

Initial CPAP/APAP/BiPAP coverage requires documented diagnostic thresholds: AHI, RDI, or REI ≥15 events/hour OR AHI/RDI/REI ≥5 events/hour with one or more signs or symptoms of OSA (e.g., excessive daytime sleepiness, hypertension, cardiovascular disease, or stroke). For pediatric patients, CPAP indicated at AHI/RDI ≥5/hr or ≥1.5/hr with excessive daytime sleepiness, behavioral problems, or hyperactivity. APAP may be used for titration or when pressure adjustment is needed for significant weight/symptom change.

• Adult initial threshold: AHI/RDI/REI ≥15 events/hour; or ≥5 events/hour with symptoms (chunks 1–3).
• Pediatric thresholds: AHI/RDI ≥5/hr; or ≥1.5/hr with symptoms (chunk 3).
• APAP may be used for titration and for significant weight/symptom changes (chunk 1).

Confirm product‑specific benefit and prior‑auth rules

Verify that this policy applies to the member's specific Capital BlueCross program/product before submitting authorization requests; the policy is only applicable to certain programs and subject to benefit variations described in Section VI.

• Policy applicability and benefit variations differ by product/program; check member-specific benefits and any program cross-references (e.g., FEP) prior to authorization (chunk 22).

Procedure and supply codes may require authorization

Many procedure, equipment, and supply codes are listed in the policy as "covered when medically necessary"; prior authorization may be required per member benefit and coverage rules. Include appropriate medical necessity documentation when submitting these codes.

• Examples of covered codes appear in the policy coding section (e.g., E0470–E0486, E0561–E0562, E0601, G0398–G0400, K1027, 94660, 95811, 0964T) but inclusion does not guarantee coverage—verify benefits (chunks 51, 49).

Prior authorization may be required for specific device/procedure codes

Certain device/procedure codes had recent status changes or additions (e.g., A7049 and temporary CPT codes 0964T–0966T) and may require payer prior authorization or be subject to updated coverage status; confirm authorization requirements before billing.

• Policy history notes movement of A7049 and addition of 0964T–0966T; these code/status changes can affect prior‑auth requirements (chunks 64, 63).
• A7049 is listed in the investigational/not covered table (chunk 50).

Prior trial of PAP required before oral appliance

Oral intraoral appliances are considered medically necessary only after a prior trial of CPAP, BiPAP, or APAP has failed, is contraindicated, or has been refused; document the trial and reason for switching.

• The policy requires a failed, contraindicated, or refused trial of PAP therapy before oral appliance coverage (chunk 8).
• Custom fitting by qualified dental personnel and physician prescription are also required for oral appliances (chunk 8).

Sequence pediatric therapy: surgery first, CPAP if needed

In pediatric patients, adenotonsillectomy is usually first‑line; CPAP is an option when surgery is not appropriate or when surgical response is inadequate—document surgical candidacy and reason for using CPAP.

• First‑line pediatric therapy is typically adenotonsillectomy; CPAP indicated for noncandidates or inadequate surgical response (chunk 19).
• Pediatric diagnostic/scoring criteria differ and should be documented (chunks 28–29).

Document conventional treatment pathway and APAP titration

Follow conventional management pathways (weight loss, stimulant avoidance, position, oral appliances, CPAP/APAP); APAP may be used to determine effective pressure prior to fixed CPAP—document prior conservative measures and rationale for device selection.

• Conventional treatments and use of APAP for titration are described as standard management options (chunks 30, 41).
• Document attempts at or contraindications to conservative measures when relevant (chunk 30).

Document adherence and in‑person evaluation for continuation/replacement

For continuation of therapy and replacement after the 5‑year reasonable useful lifetime (RUL), document objective device adherence (usage data) and a face‑to‑face clinical re‑evaluation showing symptom improvement; for replacement after RUL an in‑person evaluation must document continued use and benefit.

• Adherence requirement for continued coverage: ≥2 hours/night for 70% of nights over a continuous 30‑day period, assessed at the end of the initial 90 days (chunk 5).
• If device is replaced following the 5‑year RUL, an in‑person evaluation documenting continued use and benefit is required; no new sleep test or trial is required (chunk 6).

Required diagnostic documentation (PSG elements and home testing)

Diagnostic testing documentation should include attended polysomnography parameters (EEG, EMG, EOG, ECG, respiratory airflow and effort, snoring, oxygen saturation, sleep position); when home testing is used, report REI if EEG-derived sleep time is unavailable.

• Attended PSG typically records EEG/EMG/EOG/ECG plus respiratory airflow/effort, oximetry, snoring, and sleep position and supports split‑night titration (chunk 27).
• Home sleep apnea tests record fewer channels; use REI (events per monitoring hour) when EEG sleep time is not available (chunks 28–29).

Ensure coding submissions include medical‑necessity documentation

When submitting codes, include documentation demonstrating medical necessity per policy criteria; the coding list is not a guarantee of coverage—coverage is determined by member benefit terms.

• The coding section states that listing a code does not denote coverage; providers must document medical necessity per the policy (chunk 49).
• Ensure submitted ICD‑10 and procedure codes align with documented indications and benefit terms (chunk 51).

Follow CMS NCD 240.4 documentation expectations for CPAP

Align documentation with CMS guidance where applicable—the policy references CMS NCD 240.4 for CPAP therapy and CMS transmittals as expectations for CPAP coverage documentation.

• Reference CMS NCD 240.4 for CPAP coverage and follow CMS documentation expectations cited in the policy (chunk 63).

Denial risk: missing adherence or re‑evaluation documentation

Failure to document objective adherence (≥2 hours/night for 70% of nights over 30 days assessed at end of initial 90 days) and lack of a face‑to‑face re‑evaluation showing symptom improvement may result in denial of continued CPAP/BiPAP/APAP coverage; replacements prior to 5‑year RUL for misuse/abuse may be denied as investigational.

• Non‑documentation of adherence per the specified threshold is a denial risk for continuation (chunk 5).
• Replacement due to misuse, abuse, or negligence is investigational and may be denied (chunk 7).

Denial risk from product variations and benefit limits

Product/program benefit variations can change coverage and prior‑authorization requirements; failure to follow product‑specific rules may trigger denials—verify member‑level benefits.

• The policy is applicable only to certain programs and subject to benefit variations; check Section VI or product documentation (chunk 22).

Investigational devices/procedures will be denied

Devices or procedures listed as investigational (e.g., A7049, E0490–E0493, E0530, E1399) are not covered and may be denied if submitted for reimbursement.

• Investigational/not covered codes are explicitly listed in the policy coding section (A7049; E0490–E0493; E0530; E1399) (chunk 50).

Denial risk from coding changes or incorrect codes

Coding status changes (for example, movement of A7049 and addition of temporary codes 0964T–0966T) can affect coverage determinations and create denial risk if incorrect or outdated codes are submitted; confirm current code status before billing.

• Policy history documents movement of A7049 and addition of 0964T–0966T—these changes may alter coverage status (chunk 64).
• A7049 is listed among investigational codes in the coding table (chunk 50).